Insights from AUA 2024 Annual Meeting
R

AUA 2024 Insights: "MoonRISe-1 Study - Erdafitinib-Releasing Intravesical Delivery System (TAR-210) vs. Intravesical Chemo in Intermediate-Risk NMIBC With FGFR Alterations"

By Insights from AUA 2024 Annual Meeting FEATURING Roger Li
By Insights from AUA 2024 Annual Meeting FEATURING Roger Li
70 views
May 23, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
RENALC-BLADDR-PROSCA 2024

BLADDR 2024 - Hybrid Global Forum on GU Oncology

Wed, Nov 27, 2024
09:55

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.3K views
16:05

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views
20:41

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

1.4K views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.8K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.1K views
21:08

Updates in the Treatment and Management of Bladder Cancer

Integrity CE

M. Galsky, B. Guercio

272 views
15:58

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers

525 views
07:40

ESMO 2024 Summary: Practice-Changing Trials for Patients With Locali…

2024 ESMO Annual Meeting Insights Hub

P. Grivas

238 views
08:54

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

215 views
10:19

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

University of Colorado Cancer Center

T. Flaig

337 views
06:32

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

2024 ESMO Annual Meeting Insights Hub

E. Plimack

163 views
22:07

Urothelial Carcinoma: New Developments

Weill Cornell Medicine Oncology & Hematology

C. Sternberg

337 views
15:28

ASCO® 2024 Summary: "Bladder and RCC Highlights"

2024 ASCO® Annual Meeting Insights Hub

K. Tawagi, N. Reizine

261 views
14:00

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Carcino…

Insights from 2024 ASCO® GU Annual Meeting

G. Sonpavde

409 views
19:30

Sequencing 1L Therapies in Metastatic Urothelial Carcinoma

Scripps Health

P. Grivas

318 views
25:32

Multidisciplinary Approaches for Muscle Invasive Bladder Cancer

Memorial Sloan Kettering Cancer Center

B. Bochner

195 views
06:01

ESMO 2023 Insights: "Phase 3 EV-302 Trial - Evaluating the Combinati…

ecancer

T. Powles

508 views
20:20

The Role of Biomarkers in Urothelial Carcinoma: Current Status and F…

Miami Cancer Institute Precision Oncology Symposium

S. Gupta

183 views
04:16

ASCO® 2024 Insights: "KEYNOTE-361 Trial - Quantitative ctDNA Assessm…

2024 ASCO® Annual Meeting Insights Hub

T. Powles

185 views
13:54

FDA Approval of Gemcitabine-Cisplatin + Nivo as 1L Therapy for Advan…

AdventHealth

G. Sonpavde

274 views